Exact Sciences (EXAS) soared 28% on a report that Abbott Laboratories (ABT) is nearing a possible takeover of the medical-testing company.
Abbott (ABT) is discussing the terms of a deal with Exact Sciences (EXAS), according to a Bloomberg report on Wednesday, which cited people familiar with the matter. Talks are ongoing and could be delayed, or a deal could not come to fruition.
Exact Sciences has a market cap of $13.2 billion.
Abbott and Exact Sciences didn’t immediately respond to Bloomberg requests for comment.